
European biotech mapped: 89 startups reshaping medicine
THE SO WHAT
An indexed map of 89 European biotechs is a hiring and partnership roadmap — not a curiosity. If you’re a non-European operator in pharma, tools, or infra, treat this as a sourcing list for BD and acqui-hire before valuations re-rate.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureCan Neko's unflattering avatars actually change behaviour?
If Neko’s unflattering avatars nudge people into earlier diagnostics, the real moat isn’t scanning hardware — it’s behavior design layered on top of longitudinal health data. Any preventive health product without a tight loop between insight, emotion, and follow-through will look shallow next to this.
Startups & VentureNeko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’
Clinic-level profitability at 100k members plus a $700M Series C implies investors are underwriting a network-effects bet on longitudinal health data, not just premium scans. If you’re in diagnostics or primary care, assume the bar for “baseline imaging + AI interpretation” just moved from feature to expected standard in affluent markets.
Startups & VentureDaniel Ek's Neko Health, which offers AI-based full-body scans, raised $700M co-led by Lightspeed and O.G. Venture Partners, sources say at a ~$7B valuation
A ~$7B valuation on AI full-body scans is a bet that preventive imaging plus software can become a consumer health gateway, not a boutique service. Incumbent providers should assume that “annual full-body scan + AI risk report” will be a standard employer benefit in high-income segments within a few cycles.
Startups & VentureNYC-based Hadrius, which provides AI-native compliance tools for financial services, raised a $22M Series A led by CRV with participation from Y Combinator
AI-native compliance for financial services is moving from experiment to funded category — a $22M Series A means regulators will soon be seeing these tools in the wild. If you run a regulated shop, you should be piloting AI for surveillance and documentation now, or you’ll be reacting to standards set by your peers and vendors.